Ameriprise
EXAS

Ameriprise’s Exact Sciences EXAS Stock Holding History

Ameriprise’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,100
Closed -$2.13M – 4095
2025
Q2 		$2.13M Buy
+40,100
New +$2.04M ﹤0.01% 2923

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Ameriprise's EXAS Position: Q1 2026 in Review

Ameriprise sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,717,958 shares — an estimated $174M sold.

Ameriprise first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $470M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ameriprise reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 1,717,958 Exact Sciences shares in Q1 2026, an estimated $174M.
  • Ameriprise first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Ameriprise's Exact Sciences position peaked at $470M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.